Today's Stock Analyst Initiations and New Coverage

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ACOG Alpha Cognition	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Deschner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.41 -1.3%	$20.00	Moderate Buy
ACOG Alpha Cognition	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Deschner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.41 -1.3%	$20.00	Outperform
AGCO AGCO	Initiated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Shlisky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$114.54 +1.1%	$160.00	Buy
AMPX Amprius Technologies	Initiated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Sullivan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.53 -3.0%	$30.00	Buy
AMR Alpha Metallurgical Resources	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Eadie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$146.31 -2.4%	$165.00	Neutral
AMR Alpha Metallurgical Resources	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Eadie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$146.31 -2.4%	$165.00	Neutral
DLR Digital Realty Trust	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Catherwood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$180.39 +0.6%	$215.00	Buy
DLR Digital Realty Trust	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Catherwood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$180.39 +0.6%	$215.00	Buy
EQIX Equinix	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Catherwood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,051.21 +1.6%	$1,210.00	Buy
EQIX Equinix	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Catherwood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,051.21 +1.6%	$1,210.00	Buy
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
HLI Houlihan Lokey	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$135.40 -0.8%	$164.00	Buy
HNVR Hanover Bancorp	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Kroll Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.61 +3.5%	$26.50	Overweight
HONA Honeywell Aerospace	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Seifman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$220.75 -1.1%	$255.00	Neutral
HYMC Hycroft Mining	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Soundarya Iyer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.38 -1.9%	$28.00	Buy
IBM International Business Machines	Initiated by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$287.85 -2.5%	$303.00	Neutral
LKFT Lakefront Biotherapeutics American Depositary Shares	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$30.27 -1.0%	$30.00	Equal Weight
ROP Roper Technologies	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Jester Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$355.90 0.0%	$393.00	Market Perform
ROP Roper Technologies	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Jester Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$355.90 0.0%	$393.00	Market Perform
SHOP Shopify	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$122.54 -0.5%		Outperform ➝ Market Perform
SHOP Shopify	Initiated by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$122.54 -0.5%		Neutral
SHOP Shopify	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$122.54 -0.5%		Buy
TRV Travelers Companies	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Hughes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$338.80 +0.4%	$395.00	Buy
XFOR X4 Pharmaceuticals	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derek Archila Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.41 +11.4%	$11.00	Overweight
XFOR X4 Pharmaceuticals	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derek Archila Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.41 +11.4%	$11.00	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 07:17 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Initiations

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Initiations

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools